claim
Moshe Arditi hypothesized that discovering protein-level similarities between SARS-CoV-2 and the bacterial structure causing toxic shock syndrome could improve treatments for both MIS-C patients and adults with COVID-19 experiencing cytokine storms.

Authors

Sources

Referenced by nodes (3)